Check out what we have in store for you in the March Mid-Month Newsletter
In this edition of the HCV Advocate Mid-Month Newsletter we have the following articles:
- HCV Drugs by Alan Franciscus – Good news for our Veterans about access to hepatitis C treatment, a refresher course on AbbVie’s phase 2 clinical trial data from The Liver Meeting 2015, and Benitech’s clinical trial termination.
- SnapShots -In this issue, I write about an abstract about SVR4, SVR12, and SVR24 to evaluate which one if any can replace SVR24 (cure). In the last issue of Snapshots I wrote about a study of the protective properties of statins—the study in this edition of SnapShots looks at the statins that offer can provide the best protection for the liver. The last abstract is a pooled analysis of hepatitis C prevalence in people with HIV.
- Hepatitis C Book Review: “Undetectable” by Kim Goldberg —reviewed by Lucinda K. Porter, RN – read Lucinda’s review about this fascinating book about Kim’s journey with hepatitis C.
- HCV Advocate Monthly Pipeline Update – we have updated and expanded out Drug Pipeline.
- What’s Up!
Thank you for your continued support and inspiration,
The staff of the HCV Advocate